IHAM
ITCI
Integral Health Asset Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-145,000
| Closed | -$9.93M | – | 99 |
|
|
2024
Q2 | $9.93M | Buy |
145,000
+20,000
| +16% | +$1.37M | 0.94% | 31 |
|
|
2024
Q1 | $8.65M | Sell |
125,000
-50,000
| -29% | -$3.46M | 0.8% | 46 |
|
|
2023
Q4 | $12.5M | Buy |
175,000
+42,000
| +32% | +$3.01M | 1.71% | 20 |
|
|
2023
Q3 | $6.93M | Sell |
133,000
-9,000
| -6% | -$469K | 0.96% | 41 |
|
|
2023
Q2 | $8.99M | Buy |
+142,000
| New | +$8.99M | 1.11% | 36 |
|
|
2022
Q3 | – | Sell |
-78,277
| Closed | -$4.47M | – | 80 |
|
|
2022
Q2 | $4.47M | Buy |
78,277
+38,277
| +96% | +$2.18M | 0.92% | 37 |
|
|
2022
Q1 | $2.45M | Buy |
+40,000
| New | +$2.45M | 0.64% | 53 |
|
|
2021
Q1 | – | Sell |
-30,000
| Closed | -$954K | – | 86 |
|
|
2020
Q4 | $954K | Sell |
30,000
-70,000
| -70% | -$2.23M | 0.28% | 57 |
|
|
2020
Q3 | $2.57M | Buy |
+100,000
| New | +$2.57M | 0.78% | 45 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 77 |
|